HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Richard B Warren Selected Research
Richard B Warren Research Topics
Disease
87
Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 08/2008
15
Psoriatic Arthritis
10/2022 - 04/2010
4
Oral Candidiasis (Thrush)
03/2022 - 01/2021
4
Infections
01/2021 - 01/2016
4
Rheumatoid Arthritis
01/2020 - 02/2015
4
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020 - 04/2010
3
Skin Diseases (Skin Disease)
03/2022 - 01/2020
3
Crohn Disease (Crohn's Disease)
03/2017 - 04/2010
2
Atopic Dermatitis (Atopic Eczema)
10/2022 - 04/2020
2
Melanoma (Melanoma, Malignant)
01/2021 - 01/2020
2
Necrosis
02/2015 - 02/2014
2
Arthritis (Polyarthritis)
02/2014 - 04/2010
1
Mycoses (Diseases, Fungus)
03/2022
1
Chronic Disease (Chronic Diseases)
01/2022
1
Respiratory Tract Infections (Respiratory Tract Infection)
01/2021
1
COVID-19
01/2021
1
Lymphoma (Lymphomas)
01/2021
1
Diarrhea
01/2021
1
Hypertension (High Blood Pressure)
01/2021
1
Alopecia Areata
04/2020
1
Genetic Predisposition to Disease (Genetic Predisposition)
01/2019
1
Rare Diseases (Rare Disease)
08/2018
1
Spondylarthropathies
10/2017
1
Ankylosing Spondylitis
10/2017
1
Ulcerative Colitis
03/2017
1
Neoplasms (Cancer)
01/2017
1
Nausea
03/2016
1
Headache (Headaches)
03/2016
1
Lethargy
03/2016
1
Spontaneous Abortion (Miscarriage)
01/2016
1
Pulmonary Valve Stenosis (Pulmonary Stenosis)
01/2016
1
Rheumatic Diseases (Rheumatism)
05/2015
1
Blindness (Hysterical Blindness)
05/2014
1
Axial Spondyloarthritis
02/2014
1
Stroke (Strokes)
10/2013
Drug/Important Bio-Agent (IBA)
23
Biological Products
IBA
10/2022 - 04/2010
17
Ustekinumab (CNTO 1275)
FDA Link
10/2022 - 03/2010
14
Pharmaceutical Preparations
IBA
10/2022 - 03/2010
14
Adalimumab (Humira)
FDA Link
10/2022 - 05/2015
9
bimekizumab
IBA
08/2022 - 01/2020
9
Interleukin-17 (Interleukin 17)
IBA
03/2022 - 06/2016
8
Methotrexate (Mexate)
FDA Link
Generic
01/2022 - 08/2008
7
Biomarkers (Surrogate Marker)
IBA
07/2022 - 04/2010
7
Interleukin-23 (Interleukin 23)
IBA
02/2022 - 04/2010
6
secukinumab
IBA
10/2022 - 01/2020
6
calcipotriene (calcipotriol)
FDA Link
Generic
10/2021 - 01/2017
6
betamethasone-17,21-dipropionate (betamethasone dipropionate)
FDA Link
Generic
10/2021 - 01/2017
6
Etanercept (Enbrel)
FDA Link
02/2020 - 05/2015
6
Interleukin-12 (IL 12)
IBA
02/2020 - 04/2010
5
ixekizumab
IBA
10/2022 - 03/2017
5
Cytokines
IBA
03/2022 - 01/2015
5
Interleukins
IBA
03/2022 - 12/2012
5
HLA-C Antigens (HLA-C)
IBA
08/2019 - 11/2010
4
Immunoglobulin A (IgA)
IBA
10/2021 - 01/2021
4
Antibodies
IBA
11/2020 - 02/2014
4
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2019 - 03/2010
3
guselkumab
IBA
10/2022 - 01/2018
3
Immunologic Factors (Immunomodulators)
IBA
10/2022 - 11/2019
3
Monoclonal Antibodies
IBA
10/2021 - 03/2017
3
Tumor Necrosis Factor Inhibitors
IBA
01/2021 - 01/2019
3
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
11/2020 - 08/2018
3
brodalumab
IBA
02/2020 - 01/2019
2
RNA (Ribonucleic Acid)
IBA
10/2022 - 01/2020
2
apremilast
IBA
07/2022 - 06/2016
2
risankizumab
IBA
02/2022 - 02/2020
2
Prostaglandins A
IBA
10/2021 - 11/2020
2
Peroxidase (Myeloperoxidase)
IBA
04/2021 - 01/2020
2
Chromatin
IBA
01/2021 - 01/2020
2
Janus Kinase Inhibitors
IBA
04/2020 - 01/2016
2
Certolizumab Pegol
FDA Link
02/2020 - 06/2019
2
Infliximab (Remicade)
FDA Link
02/2020 - 04/2010
2
tildrakizumab
IBA
02/2020 - 02/2017
2
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 08/2008
2
Proteins (Proteins, Gene)
FDA Link
01/2020 - 11/2017
2
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2018 - 09/2008
2
Aerosols
IBA
06/2017 - 01/2017
2
Retinoids
IBA
01/2016 - 09/2008
1
deucravacitinib
IBA
07/2022
1
TYK2 Kinase (Tyrosine Kinase 2)
IBA
07/2022
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
11/2020
1
dupilumab
IBA
04/2020
1
Interleukin-1 (Interleukin 1)
IBA
08/2018
1
Asparagine
IBA
10/2017
1
Serine (L-Serine)
FDA Link
10/2017
1
Amino Acids
FDA Link
10/2017
1
HLA-B Antigens (HLA-B)
IBA
10/2017
1
Betamethasone (Celestone)
FDA Link
06/2017
1
Enzymes
IBA
03/2016
1
6-chloro-2-(1-piperazinyl)pyrazine (CPP)
IBA
03/2016
1
tofacitinib
IBA
01/2016
Therapy/Procedure
31
Biological Therapy
10/2022 - 09/2008
31
Therapeutics
03/2022 - 08/2008
2
Phototherapy (Light Therapy)
01/2022 - 01/2016
2
Subcutaneous Injections
01/2020 - 08/2018
1
Oral Hygiene (Dental Hygiene)
03/2022
1
Aftercare (After-Treatment)
11/2020
1
Transcutaneous Electric Nerve Stimulation (TENS)
06/2017
1
Injections
01/2017
1
Immunotherapy
01/2015